New Alternative to Antidotes for Novel Oral Anticoagulants and Ticagrelor in the Case of Severe Bleeding

Critical Care - United Kingdom
doi 10.1186/s13054-020-2760-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Novel Antidotes for Target Specific Oral Anticoagulants

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2015English

Delayed Bleeding After Implant Surgery in Patients Taking Novel Oral Anticoagulants: A Case Report

Journal of Dental Anesthesia and Pain Medicine
2017English

New Oral Anticoagulants in the Treatment of Pulmonary Embolism: Efficacy, Bleeding Risk, and Monitoring

Thrombosis
Cardiovascular MedicineHematologyCardiology
2013English

Bleeding Complications From the Direct Oral Anticoagulants

BMC Hematology
HematologyMolecular Biology
2015English

Novel Oral Anticoagulants and Risk

Clinical Oral Implants Research
Oral Surgery
2018English

The Hope for Novel Oral Anticoagulants and Related Problems

Folia Pharmacologica Japonica
Pharmacology
2014English

Novel Oral Anticoagulants for Acute Coronary Syndrome

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2016English

Active Online Assessment of Patients Using New Oral Anticoagulants: Bleeding Risk, Compliance, and Coagulation Analysis

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2012English

Evidence of Novel Oral Anticoagulants (NOAC)

Clinical Neurology
Neurology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy